Cargando…

Is There A Systemıc Inflammatory Effect of Cholesteatoma?

Introduction Inflammation causes squamous epithelial transformation of the mucosa in the middle ear cavity and plays a role in the onset, growth, spread, and recurrence of cholesteatoma. Objectives The objective of this study is to investigate the systemic inflammatory effect in chronic otitis with...

Descripción completa

Detalles Bibliográficos
Autores principales: Kılıçkaya, M. Mustafa, Aynali, Giray, Tuz, Mustafa, Bagcı, Özkan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme-Revinter Publicações Ltda 2016
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5205518/
https://www.ncbi.nlm.nih.gov/pubmed/28050207
http://dx.doi.org/10.1055/s-0036-1584363
_version_ 1782490093657784320
author Kılıçkaya, M. Mustafa
Aynali, Giray
Tuz, Mustafa
Bagcı, Özkan
author_facet Kılıçkaya, M. Mustafa
Aynali, Giray
Tuz, Mustafa
Bagcı, Özkan
author_sort Kılıçkaya, M. Mustafa
collection PubMed
description Introduction Inflammation causes squamous epithelial transformation of the mucosa in the middle ear cavity and plays a role in the onset, growth, spread, and recurrence of cholesteatoma. Objectives The objective of this study is to investigate the systemic inflammatory effect in chronic otitis with cholesteatoma. Methods The study included a total of 311 patients comprising 156 patients with a pathology diagnosis of cholesteatoma and a control group of 155 with no active inflammation. The Neutrophil-to-lymphocyte Ratio (NLR) was calculated by dividing the neutrophil value by the lymphocyte value. Results The mean NLR was 1.94 ± 0.91 in the patients with cholesteatoma and 1.94 ± 0.85 in the control group. We determined no statistically significant difference between the groups in respect of NLR (p = 0.983). We calculated the NLR as 2.01 ± 1.00 in patients with ossicle erosion and 1.82 ± 0.69 in those without ossicle erosion, 1.86 ± 0.85 in patients with bone erosion and 1.98 ± 0.95 in those without bone erosion. We determined no statistical difference between these values (p = 0.175). Conclusion The results of this study showed that NLR had no predictive value in respect of bone erosions and associated complications in patients with cholesteatoma. The inflammatory effect of cholesteatoma is not systemic but remains more local.
format Online
Article
Text
id pubmed-5205518
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Thieme-Revinter Publicações Ltda
record_format MEDLINE/PubMed
spelling pubmed-52055182017-01-03 Is There A Systemıc Inflammatory Effect of Cholesteatoma? Kılıçkaya, M. Mustafa Aynali, Giray Tuz, Mustafa Bagcı, Özkan Int Arch Otorhinolaryngol Introduction Inflammation causes squamous epithelial transformation of the mucosa in the middle ear cavity and plays a role in the onset, growth, spread, and recurrence of cholesteatoma. Objectives The objective of this study is to investigate the systemic inflammatory effect in chronic otitis with cholesteatoma. Methods The study included a total of 311 patients comprising 156 patients with a pathology diagnosis of cholesteatoma and a control group of 155 with no active inflammation. The Neutrophil-to-lymphocyte Ratio (NLR) was calculated by dividing the neutrophil value by the lymphocyte value. Results The mean NLR was 1.94 ± 0.91 in the patients with cholesteatoma and 1.94 ± 0.85 in the control group. We determined no statistically significant difference between the groups in respect of NLR (p = 0.983). We calculated the NLR as 2.01 ± 1.00 in patients with ossicle erosion and 1.82 ± 0.69 in those without ossicle erosion, 1.86 ± 0.85 in patients with bone erosion and 1.98 ± 0.95 in those without bone erosion. We determined no statistical difference between these values (p = 0.175). Conclusion The results of this study showed that NLR had no predictive value in respect of bone erosions and associated complications in patients with cholesteatoma. The inflammatory effect of cholesteatoma is not systemic but remains more local. Thieme-Revinter Publicações Ltda 2016-06-06 2017-01 /pmc/articles/PMC5205518/ /pubmed/28050207 http://dx.doi.org/10.1055/s-0036-1584363 Text en © Thieme Medical Publishers
spellingShingle Kılıçkaya, M. Mustafa
Aynali, Giray
Tuz, Mustafa
Bagcı, Özkan
Is There A Systemıc Inflammatory Effect of Cholesteatoma?
title Is There A Systemıc Inflammatory Effect of Cholesteatoma?
title_full Is There A Systemıc Inflammatory Effect of Cholesteatoma?
title_fullStr Is There A Systemıc Inflammatory Effect of Cholesteatoma?
title_full_unstemmed Is There A Systemıc Inflammatory Effect of Cholesteatoma?
title_short Is There A Systemıc Inflammatory Effect of Cholesteatoma?
title_sort is there a systemıc inflammatory effect of cholesteatoma?
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5205518/
https://www.ncbi.nlm.nih.gov/pubmed/28050207
http://dx.doi.org/10.1055/s-0036-1584363
work_keys_str_mv AT kılıckayammustafa isthereasystemıcinflammatoryeffectofcholesteatoma
AT aynaligiray isthereasystemıcinflammatoryeffectofcholesteatoma
AT tuzmustafa isthereasystemıcinflammatoryeffectofcholesteatoma
AT bagcıozkan isthereasystemıcinflammatoryeffectofcholesteatoma